Product Information
DOXYCYCLINE IR-DR 40 MG CAP is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $4.6707 per EA under NDC 70748030806. Its NADAC has been published 122 times since Jun 5, 2024.
FDA first approved this application on Apr 8, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
40 mg/1
Manufacturer
Lupin Pharmaceuticals Inc.NDC
70748030806
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DOXYCYCLINEApproval Type
Generic (ANDA)
FDA Application
ANDA216631FDA Approved
4/8/2024
TE Code
AB
On Market Since
4/8/2024
Pharmacological Classes
Price Statistics
The NADAC for DOXYCYCLINE IR-DR 40 MG CAP has been published 122 times since Jun 5, 2024, and over the history we have for it it has declined 77.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.6707 per EA |
|---|---|
| All-time high | $22.5521 (Sep 11, 2024) |
| All-time low | $4.2949 (Aug 19, 2026) |
| 52-week high | $11.3939 |
| 52-week low | $4.2949 |
| Median price | $11.6632 |
| Average price | $12.6974 |
| Largest weekly change | -22.4% (Nov 20, 2024) |
| Weeks tracked | 122 |
| Tracking since | Jun 5, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the doxycycline market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Lupin Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
doxycycline market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Tetracycline-class Drug class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DOXYCYCLINE IR-DR 40 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for DOXYCYCLINE IR-DR 40 MG CAP, manufactured by Lupin Pharmaceuticals Inc., is $4.6707 per EA (NDC 70748030806), effective Sep 30, 2026.
How has the price of DOXYCYCLINE IR-DR 40 MG CAP changed over time?
Over the history we have for it, the NADAC for DOXYCYCLINE IR-DR 40 MG CAP has declined 77.8%. It has been tracked across 122 weekly CMS publications since Jun 5, 2024.
What are the highest and lowest recorded NADAC prices for DOXYCYCLINE IR-DR 40 MG CAP?
Since Jun 5, 2024, the NADAC for DOXYCYCLINE IR-DR 40 MG CAP has ranged from a low of $4.2949 (Aug 19, 2026) to a high of $22.5521 (Sep 11, 2024), with a median of $11.6632 per EA.
Are there cheaper alternatives to DOXYCYCLINE IR-DR 40 MG CAP?
No other NADAC-published product currently shares the active ingredient and strength of DOXYCYCLINE IR-DR 40 MG CAP in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures DOXYCYCLINE IR-DR 40 MG CAP?
DOXYCYCLINE IR-DR 40 MG CAP (NDC 70748030806) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.